Abstract
The diagnosis and management of fetal cardiac arrhythmias requires complex skills and knowledge, and has had a great impact on the care of infants with congenital heart disease and their families. Optimal benefits will be derived from a thoughtful team approach, with skillful internal communication, and especially when parental involvement is encouraged in the decision making process.
MeSH terms
-
Anti-Arrhythmia Agents / therapeutic use
-
Arrhythmias, Cardiac / classification
-
Arrhythmias, Cardiac / diagnosis*
-
Arrhythmias, Cardiac / drug therapy
-
Digoxin / therapeutic use
-
Electrocardiography
-
Female
-
Fetal Diseases / classification
-
Fetal Diseases / diagnosis*
-
Fetal Diseases / drug therapy
-
Fetal Monitoring
-
Humans
-
Infant, Newborn
-
Pregnancy
Substances
-
Anti-Arrhythmia Agents
-
Digoxin